This inventor holds 1 USPTO granted patent. Top assignee: Dainippon Pharmaceutical Company, Limited. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Akemi Kuromiya: Innovator in Elastase-Inhibiting Compounds
Introduction
Akemi Kuromiya is a notable inventor based in Daito, Japan. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that exhibit elastase-inhibiting activity. Her work is crucial in the pursuit of therapeutic agents that can combat various diseases.
Latest Patents
Kuromiya holds a patent for "Heterocyclic compounds having elastase-inhibiting activity and intermediates thereof." This patent describes heterocyclic compounds represented by a specific general formula, which possess elastase-inhibiting properties. The compounds can be modified with various substituents, enhancing their potential therapeutic applications.
Career Highlights
She is currently employed at Dainippon Pharmaceutical Company, Limited, where she continues her research and development efforts. Her innovative work has positioned her as a key figure in her field, contributing to advancements in drug development.
Collaborations
Throughout her career, Kuromiya has collaborated with esteemed colleagues such as Ryotaro Shiratake and Fuminori Sato. These partnerships have fostered a collaborative environment that enhances the research output and innovation within her team.
Conclusion
Akemi Kuromiya's contributions to the field of elastase-inhibiting compounds highlight her role as a pioneering inventor. Her work not only advances scientific knowledge but also holds promise for future therapeutic developments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
